
Baudax Bio BXRX
Quarterly report 2023-Q3
added 11-20-2023
Baudax Bio DIO Ratio 2011-2026 | BXRX
Annual DIO Ratio Baudax Bio
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 596 | 628 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 628 | 596 | 612 |
Quarterly DIO Ratio Baudax Bio
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 368 | 1.32 K | 719 | - | 777 | 493 | 320 | - | 503 | 418 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.32 K | 320 | 615 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
4.89 | $ 0.84 | - | $ 4.58 M | ||
|
Axsome Therapeutics
AXSM
|
168 | $ 166.38 | - | $ 8.28 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Codexis
CDXS
|
50.2 | $ 1.02 | - | $ 74.9 M | ||
|
Agenus
AGEN
|
0.163 | $ 3.34 | 0.3 % | $ 1.2 M | ||
|
Agios Pharmaceuticals
AGIO
|
1.74 K | $ 29.2 | -3.41 % | $ 1.69 B | ||
|
Завод ДИОД
DIOD
|
768 | - | - | - | ||
|
Фармсинтез
LIFE
|
120 | - | - | - | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
23.3 | $ 3.8 | -2.06 % | $ 116 M | ||
|
Teligent, Inc.
TLGT
|
198 | - | -13.85 % | $ 16.1 M | ||
|
Amarin Corporation plc
AMRN
|
292 | $ 13.93 | 0.94 % | $ 5.78 B | ||
|
AbbVie
ABBV
|
91.6 | $ 234.26 | 0.94 % | $ 414 B | ||
|
Blueprint Medicines Corporation
BPMC
|
315 | - | - | $ 8.14 B | ||
|
AIM ImmunoTech
AIM
|
303 | $ 0.77 | -14.64 % | $ 37 M |